References
- 1. Monova D, Monov S. Lupus nephritis. Nephrology (ed. E. Paskalev), 2015, Sofia, Bulgarresurs 7: 295-312.
- 2. Almaani, Meara S, Rovin A. Update on Lupus Nephtitis, CJASN, 2017,12(5):825-835.
- 3. Anders HJ, Saxena R, Zhao M et al. Lupus nephrtitis. Nature Reviews Disease Primers, 2020,6:7.
- 4. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. Atlanta, GA: US Department of Health and Human Services; 2011. [Accessed September 2, 2014 Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
- 5. Chen YE, Korbet SM, Katz RS et al. Collaborative Study Group. Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol, 2008,3:46-53.
- 6. Cortes S, Chambers S, Jeronimo A, Isenberg D. Diabetes mellitus complicating systemic lupus erytematosus-analysis of the UCL lulus cohort and revuew of the literature. Lupus, 2008,17:977-980.
- 7. Mooyaart AL, Valk EJ, van Es LA, et al. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia. 2011;54(3):544–553.
- 8. Morales E, Galindo M, Trujillo H, Praga M. Update on Lupus Nephritis: Looking for a New Vision. Nphron, 2021,145:1-13.
- 9. Parikh SV, Almaani S, Brodsky S, Rovin BH. AJKD, 2020,76:265-281.
- 10. Pettitt DJ, Saad MF, Bennett PH et al. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1990;33(7):438-443.
- 11. Pottathil R, Huang SW, Chandrabose KA. Essential fatty acids in diabetes and systemic lupus erytematosus (SLE) patients. Biochem Biophys Res Commun, 1985,128:803-808.
- 12. Satko SG, Langefeld CD, Daeihagh P et al. Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. Am J Kidney Dis. 2002;40(3):489.
- 13. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989;320(18):1161-1165.
- 14. Tektonidou M, Dasgupta A, Ward M. Risu of end stage renal disease in patients with lulus nephritis, 1970-2015: a systematic review and Bayesian meta analysis. Arthritis Rheumatol, 2016,68:1432-1441.
- 15. Wu J, Zhou Z, Ye S et al. Detection of soluble endothelial protein C receptor (sEPCR) in patients with CHD, DM and SLE. Zhonghua Xue Ye Xue Za Zhi. 2000 Sep;21(9):472-4.